Bluesky Facebook Reddit Email

Vaccine side effects should be welcomed as a sign of efficacy, immunologists say in new focus

06.22.21 | American Association for the Advancement of Science (AAAS)

Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

The rapid development of safe and efficacious vaccines against SARS-CoV-2 has offered hope that the global COVID-19 pandemic may soon be under control. However, vaccinations remain incomplete in many developed nations, and lag further still in the developing world. In a new Focus, Jonathan Sprent and Cecile King posit that vaccine hesitancy, motivated in part by fear of side effects documented in scientific journals and the popular media, could hold back the global population from reaching herd immunity. Seeking to reassure those with reservations, Sprent and King suggest that "it is highly likely - albeit not proven - that the side effects of COVID-19 vaccines are simply a by-product of a short burst of [type I interferon] generation concomitant with induction of an effective immune response." Thus, they contend that "the prospect of fatigue and headache after vaccination for COVID-19 should be viewed positively: as a necessary prelude to an effective immune response."

###

Science Immunology

10.1126/sciimmunol.abj9256

Keywords

Article Information

Contact Information

How to Cite This Article

APA:
American Association for the Advancement of Science (AAAS). (2021, June 22). Vaccine side effects should be welcomed as a sign of efficacy, immunologists say in new focus. Brightsurf News. https://www.brightsurf.com/news/LMJ2N24L/vaccine-side-effects-should-be-welcomed-as-a-sign-of-efficacy-immunologists-say-in-new-focus.html
MLA:
"Vaccine side effects should be welcomed as a sign of efficacy, immunologists say in new focus." Brightsurf News, Jun. 22 2021, https://www.brightsurf.com/news/LMJ2N24L/vaccine-side-effects-should-be-welcomed-as-a-sign-of-efficacy-immunologists-say-in-new-focus.html.